Natalizumab: Bound to rebound?

Nicoline Schiess; Peter A. Calabresi

doi:10.1212/01.wnl.0000341783.33962.5b

Natalizumab: Bound to rebound?

Nicoline Schiess, Peter A. Calabresi

School of Medicine

Research output: Contribution to journal › Editorial › peer-review

16 Scopus citations

Original language	English (US)
Pages (from-to)	392-393
Number of pages	2
Journal	Neurology
Volume	72
Issue number	5
DOIs	https://doi.org/10.1212/01.wnl.0000341783.33962.5b
State	Published - Feb 3 2009

ASJC Scopus subject areas

Clinical Neurology

Access to Document

10.1212/01.wnl.0000341783.33962.5b

Cite this

@article{02b20c47f3f94112b91715bedb37b81d,

title = "Natalizumab: Bound to rebound?",

author = "Nicoline Schiess and Calabresi, {Peter A.}",

year = "2009",

month = feb,

day = "3",

doi = "10.1212/01.wnl.0000341783.33962.5b",

language = "English (US)",

volume = "72",

pages = "392--393",

journal = "Neurology",

issn = "0028-3878",

publisher = "Lippincott Williams and Wilkins",

number = "5",

}

TY - JOUR

T1 - Natalizumab

T2 - Bound to rebound?

AU - Schiess, Nicoline

AU - Calabresi, Peter A.

PY - 2009/2/3

Y1 - 2009/2/3

UR - http://www.scopus.com/inward/record.url?scp=61549089098&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=61549089098&partnerID=8YFLogxK

U2 - 10.1212/01.wnl.0000341783.33962.5b

DO - 10.1212/01.wnl.0000341783.33962.5b

M3 - Editorial

C2 - 19188569

AN - SCOPUS:61549089098

SN - 0028-3878

VL - 72

SP - 392

EP - 393

JO - Neurology

JF - Neurology

IS - 5

ER -

Natalizumab: Bound to rebound?

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this